Connect with us

News

Symantec Discovers Highly Sophisticated Chinese Hacking Tool

In its research report, Symantec calls the tool Daxin and describes it as the most advanced piece of malware researchers have seen.

Published

on

symantec discovers highly sophisticated chinese cyber espionage tool

In August 2021, the Cybersecurity and Infrastructure Security Agency (CISA) established the Joint Cyber Defense Collaborative (JCDC), a public-private cybersecurity information sharing partnership whose purpose is to unify defensive actions and drive down risk in advance of cyber incidents occurring. Now, one JCDC member, American cybersecurity software company Symantec, has discovered a never-before-seen hacking tool that has been successfully hiding for over a decade.

In its research report, Symantec calls the tool Daxin and describes it as the most advanced piece of malware Symantec researchers have seen.

Based on instances where components of the tool were combined with known Chinese hacking infrastructure, it’s almost certain that Daxin has originated from China. What’s more, the computers on which Daxin was discovered were also infected with other tools Chinese espionage actors are known to use.

symantec daxin methodology

“The malware appears to be used in a long-running espionage campaign against select governments and other critical infrastructure targets” explains Symantec’s Treat Hunter Team. “Most of the targets appear to be organizations and governments of strategic interest to China”.

Daxin allows attackers to perform various communications and data-gathering operations, and it appears to be optimized to perform especially well against hardened targets that can withstand less sophisticated attacks.

Also Read: How To Change Your Wi-Fi Password To Keep Intruders At Bay

“Daxin can be controlled from anywhere in the world once a computer is actually infected” said Vikram Thakur, a technical director with Symantec. “That’s what raises the bar from malware that we see coming out of groups operating from China”.

Since the initial discovery of Daxin, the U.S. government has shared the information with foreign partners to collectively stop the tool from spreading from country to country and from network to network.

So far, no organization in the United States has been infected by Daxin, but previous experience with malware like NotPetya, which was created by Russia to attack Ukrainian infrastructure, tells us that heightened caution is appropriate.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Orchid Plans To Find Out What’s Wrong With You Before You’re Born

According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.

Published

on

startup orchid plans to find out what's wrong with you before you're born
Orchid

Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.

Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.

Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.

“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.

Also Read: Advancing MENA Health Through AI Vascular Age Analysis

Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.

Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.

Continue Reading

#Trending